57282-49-2
57282-49-2 structure
- Name: L-Lysine monoacetate
- Chemical Name: L-Lysine acetate
- CAS Number: 57282-49-2
- Molecular Formula: C8H18N2O4
- Molecular Weight: 206.240
- Catalog: Biochemical Common amino acids and protein drugs
- Create Date: 2018-07-10 11:41:39
- Modify Date: 2026-06-30 17:47:38
-
L-Lysine acetate is an essential amino acid. L-Lysine acetate can be research for vascular calcification (VC) and Acute pancreatitis[1][2].
| Name | L-Lysine acetate |
|---|---|
| Synonyms |
ysine acetate saL
L-Lysine monoacetate //BP MFCD00039069 L-Lysinmonoacetat L-Lysine acetate (1:1) (S)-2,6-Diaminohexanoic acid, L-Lysine acetate salt (2S)-2,6-diaMinohexanoyl acetate (s)-2,6-diaminohexanoic acid acetate salt LYSINE ACETATE Lysine acetate salt L-LYSINE ACETATE L -Lysine acetate NBQX 2Na (2S)-2,6-Diaminohexanoic acid acetate EINECS 260-664-4 L-Lysineacetate(forinjection) L-Lysinemonoacetate L-Lysine acetate salt,(S)-2,6-Diaminohexanoic acid laevo-lysine acetate LYSINEACETATE DL-Lysine acetate H-LYS-OH ACOH L-Lysine, acetate Lysine acetate CRS L-LYSINE ACETATE STANDD 2,6-diaminohexanoic acid acetate L-LYSINE AC L -Lysine acetate salt H-Lys-OH Acetate (S)-2,6-diaMinohexanoic acid coMpound with acetic acid (1:1) LYSINEACETATE,USP L-Lysine Acetic acid L-LYS AC Lysine Monoacetate L-LYSINE ACETATE USP Uridine Impurity 51 L-Lysine, acetate (1:1) L-LYSINE ACETATE SALT, >= (HPLC) |
| Description | L-Lysine acetate is an essential amino acid. L-Lysine acetate can be research for vascular calcification (VC) and Acute pancreatitis[1][2]. |
|---|---|
| Related Catalog | |
| Target |
Microbial Metabolite Human Endogenous Metabolite |
| In Vitro | L-Lysine acetate (VSMCs) suppresses plasma iPTH and elevates plasma alanine, proline, plasma arginine, and homo arginine, thereby inhibiting apoptosis of VSMCs and mineral precipitation[1]. |
| In Vivo | L-Lysine acetate (40 μg/kg; p.o.) ameliorates arterial calcification in adenine rats and protects the femora from osteoporotic changes in adenine rats[1]. L-Lysine acetate (10 and 400 mg/kg; i.g. and p.o.; Male mice) inhibits pancreatic tissue damage[2]. Animal Model: Male mice[2] Dosage: 10 and 400 mg/kg Administration: Intraperitoneal injection and oral administration; for 15 days. Result: Inhibited the release of the inflammatory cytokine IL-6 and enhance antioxidant activity. |
| References |
| Boiling Point | 441ºC at 760 mmHg |
|---|---|
| Melting Point | 224ºC, decomposes |
| Molecular Formula | C8H18N2O4 |
| Molecular Weight | 206.240 |
| Flash Point | 220.5ºC |
| Exact Mass | 206.126663 |
| PSA | 126.64000 |
| LogP | 1.01880 |
| Storage condition | room temp |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xi |
| RIDADR | NONH for all modes of transport |
| RTECS | OL5644200 |
| HS Code | 2922419000 |
| HS Code | 2922419000 |
|---|